Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
Clinical trial NCT02674386 · COMPLETED
Trial details
- NCT number
- NCT02674386
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-23
- Primary completion
- 2019-07-15
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.